KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent Deferred Tax AssetsCurrent Deferred Tax AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pfizer (PFE) Cash & Current Investments (2016 - 2026)

Pfizer has reported Cash & Current Investments over the past 18 years, most recently at $13.1 billion for Q1 2026.

  • Quarterly Cash & Current Investments fell 24.5% to $13.1 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $13.1 billion through Mar 2026, down 24.5% year-over-year, with the annual reading at $13.6 billion for FY2025, 33.6% down from the prior year.
  • Cash & Current Investments was $13.1 billion for Q1 2026 at Pfizer, down from $13.6 billion in the prior quarter.
  • Over five years, Cash & Current Investments peaked at $44.8 billion in Q3 2023 and troughed at $7.1 billion in Q2 2024.
  • The 5-year median for Cash & Current Investments is $17.3 billion (2025), against an average of $21.1 billion.
  • Year-over-year, Cash & Current Investments crashed 84.15% in 2024 and then surged 86.61% in 2025.
  • A 5-year view of Cash & Current Investments shows it stood at $22.7 billion in 2022, then plummeted by 44.18% to $12.7 billion in 2023, then surged by 61.36% to $20.5 billion in 2024, then plummeted by 33.6% to $13.6 billion in 2025, then dropped by 3.83% to $13.1 billion in 2026.
  • Per Business Quant, the three most recent readings for PFE's Cash & Current Investments are $13.1 billion (Q1 2026), $13.6 billion (Q4 2025), and $15.0 billion (Q3 2025).